Zydus Wellness Limited share price

Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in Asia, the Middle East, Africa, the Oceania, Europe, and North America. It provides glucose powder under the Glucon-D brand; sugar substitute products under the Sugar Free Gold+, Sugar Free Natura, Sugar Free Green, and I'm lite brands; Milk-based nutrition drink products under the Complan brand; table spreads under the Nutralite brand; skin cleansing products under the Everyuth brand; hair color products under the Cuticolor brand; heat powder under the Nycil brand; and healthy eating products, such as snack bars, protein bars, breakfast cookies, and protein chips und…Read more

Website NSE हिंदी में BSE

Fast Moving Consumer GoodsPackaged FoodsNifty 500 Nifty Smallcap 250NSE: ZYDUSWELLISIN INE768C01028

16 Oct 2026, 3:30 PM IST₹512.75▲ 2.80 (0.55%)

Market Cap₹ 16,314 Cr.
Current Price₹ 512.75
High / Low₹ 612 / 368
Stock P/E86.6
Book Value₹ 183
Dividend Yield0.24 %
ROCE3.4 %
ROE3.40 %
Face Value₹ 2.0

More figures (10)

EPS (TTM)₹ 5.92
Price / Book2.80
OPM9.0 %
Debt / Equity0.55
Sales growth (5Y)16.2 %
Profit growth (5Y)10.7 %
Promoter holding69.9 %
EV / EBITDA34.2
Beta-0.10
All-time high₹ 612

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
ZYDUSWELL	-7.08%	-14.81%	+2.08%	+12.79%	+9.05%	+17.97%	+2.16%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Zydus Wellness Limited is in the Packaged Foods industry (Consumer Defensive), with a market value of ₹16,314 crore.
It trades at 86.6 times its last 12 months' earnings and 2.8 times book value.
Revenue grew 16.2% a year over the last 5 years, profit 10.7% a year.
Return on equity was 3.4% and return on capital employed 3.4% in the latest year.
Debt was 0.55 times shareholders' equity.
The share price is 16.2% below its 52-week high and up 9.1% over one year.
Promoters and insiders hold about 69.9%; institutions about 21.3%.

Pros

Sales have grown 16.2% a year over the last 5 years.
Promoters hold a large stake of 69.64%.

Cons

Return on equity has been low: 4.9% on average over the last 3 years.
Trades at 86.6 times earnings, above its 3-year median of 41.5.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Zydus Wellness Limited

Employees: 1,685
Head office: Ahmedabad
NSE industry: Fast Moving Consumer Goods

Consumer DefensiveFast Moving Consumer GoodsPackaged Foods

Part ofNifty 500 Nifty Smallcap 250

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	Zydus Wellness	512.75	86.6	16,314	0.24	119	-7.04	1,437	66.92	3.4	3.4	2.80	9.0	0.55	69.85	3,961	16.2
2.	Nestlé India	1,265.50	59.8	2,44,028	0.94	959	—	6,363	—	—	—	42.21	—	—	62.77	—	17.0
3.	Britannia Industries	4,764.00	44.1	1,14,750	1.87	591	5.61	4,964	13.46	61.2	53.5	22.47	17.0	0.27	51.18	18,858	5.7
4.	Tata Consumer Products	978.90	59.3	96,882	1.01	427	23.82	5,349	16.05	8.3	7.4	4.45	10.8	0.13	34.37	20,171	13.9
5.	Patanjali Foods	367.30	20.3	39,966	1.11	336	-6.36	11,337	19.19	11.2	14.8	3.05	3.8	0.21	69.50	40,142	8.7
6.	AWL Agri Business	187.30	21.0	24,196	0.52	350	84.09	20,048	9.98	15.3	10.5	2.32	2.5	0.78	69.18	74,619	8.7
7.	Milky Mist Dairy Food	303.85	126.1	23,392	0.00	65	—	973	—	15.5	32.1	42.15	8.3	3.62	85.52	3,120	31.0
8.	LT Foods	417.65	22.6	14,503	0.95	183	14.28	3,152	41.44	18.4	14.9	3.21	8.4	0.36	61.61	10,894	16.5
9.	CCL Products (India)	1,008.30	29.1	13,445	0.53	117	14.74	1,200	43.62	20.5	18.0	5.73	11.4	0.56	49.14	4,457	29.1
10.	Manorama Industries	1,911.20	46.3	12,064	0.04	79	67.55	404	39.53	47.4	39.4	16.73	24.6	0.52	67.41	1,367	57.6
	Median: 33 Co.	745.83	21.8	3,122	0.17	260	14.51	4,058	29.36	15.5	11.6	2.91	7.1	0.52	65.09	10,894	10.1

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	702	440	403	783	841	493	462	913	861	651	965	1,485	1,437
YOY Sales Growth %		2.43%	-2.98%	9.76%	19.78%	12.05%	14.56%	16.68%	2.37%	31.97%	108.90%	62.60%	66.92%
	586	423	391	620	686	473	447	723	705	628	904	1,215	1,195
Material Cost %	47%	55%	52%	45%	44%	52%	51%	45%	45%	47%	37%	35%	34%
Employee Cost %	7%	11%	11%	7%	7%	11%	11%	8%	8%	10%	8%	7%	7%
Other Expenses %	29%	30%	34%	27%	30%	33%	34%	26%	29%	39%	49%	40%	42%
Operating Profit	117	17	13	162	155	20	15	190	156	23	61	270	242
OPM %	17%	4%	3%	21%	18%	4%	3%	21%	18%	4%	6%	18%	17%
	2	4	3	4	5	4	4	1	3	1	1	1	4
Exceptional items	-14					6				-34	-7
Interest	5	7	6	6	4	1	3	4	3	16	41	39	26
Depreciation	6	6	6	6	5	5	5	13	11	25	56	55	57
Profit before tax	93	9	4	154	152	24	10	173	145	-51	-42	177	162
	-18%	31%	92%	3%	3%	12%	37%	1%	12%			9%	27%
Current tax	-0		0	0	0		0	-0	1	9	9	12	40
Deferred tax	-17	3	3	4	4	3	4	2	17	-7	-11	4	3
	110	6	0	150	148	21	6	172	128	-53	-40	162	119
Profit to shareholders	110	6	0	150	148	21	6	172	128	-53	-40	162	119
YOY Profit Growth %		-30.34%	-98.47%	3.42%	33.79%	254.24%	2,033.33%	14.37%	-13.41%	-352.63%	-723.44%	-5.76%	-7.04%
EPS in Rs	3.47	0.19	0.01	4.72	4.64	0.66	0.20	5.40	4.02	-1.66	-1.25	5.09	3.74
Raw filing

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	60	58	64	63	63	63	88	78	88	156	153	133	153
YOY Sales Growth %		-14.01%	0.13%	7.42%	5.49%	9.52%	38.56%	22.82%	38.33%	146.45%	72.62%	71.10%	74.46%
	53	50	53	56	58	56	74	69	75	128	132	113	141
Material Cost %	64%	63%	64%	64%	63%	64%	69%	65%	63%	58%	70%	64%	68%
Employee Cost %	13%	14%	9%	13%	18%	14%	10%	18%	14%	9%	8%	11%	10%
Other Expenses %	11%	10%	9%	11%	12%	10%	4%	6%	8%	15%	9%	10%	14%
Operating Profit	7	8	11	8	5	8	15	9	13	28	21	20	12
OPM %	12%	13%	17%	12%	8%	12%	17%	11%	14%	18%	14%	15%	8%
	4	5	5	5	5	4	3	0	0	2	4	5	5
Exceptional items										-10	-2
Interest		1	1	1	1	0	1	2	2	3	3	3	3
Depreciation	1	1	1	1	1	1	1	1	1	6	6	6	6
Profit before tax	10	10	14	10	8	11	16	6	10	12	14	15	7
	21%	25%	24%	29%	26%	24%	25%	24%	26%	34%	15%	13%	26%
Current tax	-0		0		0		0	-0		5	-2	0	0
Deferred tax	2	3	3	3	2	3	4	2	3	-1	4	2	2
	8	8	10	7	6	8	12	5	7	8	12	13	6
YOY Profit Growth %		-47.23%	-31.47%	-74.18%	-24.39%	2.56%	13.59%	-36.49%	12.90%	-5.00%	3.42%	182.98%	-21.43%
EPS in Rs	0.26	0.25	0.32	0.23	0.19	0.25	0.37	0.15	0.22	0.24	0.38	0.42	0.17
Raw filing

Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2018	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	503	1,767	1,867	2,009	2,255	2,328	2,709	3,961	4,537
YOY Sales Growth %		251.15%	5.65%	7.63%	12.23%	3.24%	16.37%	46.22%
	378	1,446	1,522	1,664	1,918	2,020	2,329	3,451	3,941
Material Cost %	30%	44%	45%	49%	51%	49%	47%	40%	37%
Employee Cost %	11%	10%	9%	8%	7%	8%	9%	8%	8%
Other Expenses %	34%	28%	28%	26%	27%	30%	30%	40%	42%
Operating Profit	125	321	344	345	337	308	380	510	596
OPM %	25%	18%	18%	17%	15%	13%	14%	13%	13%
	35	11	9	10	5	14	14	6	7
Exceptional items		-44	-132		-10	-14	6	-41	-41
Interest	2	140	84	26	16	24	12	98	122
Depreciation	9	26	25	24	25	24	28	147	193
Profit before tax	150	121	112	306	291	260	359	231	247
	9%	-17%	-6%	-1%	-7%	-3%	3%	14%	24%
Current tax	31	-3			-0	0	0	31
Deferred tax	-17	-18	-7	-3	-19	-7	12	3
	134	142	119	309	310	267	347	197	188
Profit from associates	-3
Profit to shareholders		144	121	308	310	267	347	197	188
YOY Profit Growth %		5.84%	-16.22%	160.14%	0.49%	-14.01%	29.97%	-43.15%
EPS in Rs	4.57	4.92	3.91	9.71	9.76	8.39	10.90	6.20	5.92
Dividend Payout %					10%	12%	9%	19%

Compounded Sales Growth

5 Years:: 16%
3 Years:: 21%
TTM:: 66%

Compounded Profit Growth

5 Years:: 11%
3 Years:: -14%
TTM:: -42%

Stock Price CAGR

5 Years:: 2%
3 Years:: 18%
1 Year:: 9%

Return on Equity

4 Years:: 5%
Last Year:: 3%

₹ Cr	Mar 2018	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	265	153	114	216	251	245	293	582	594
YOY Sales Growth %		-42.08%	-25.81%	89.98%	16.29%	-2.66%	19.53%	98.94%
	153	174	164	222	213	212	256	498	514
Material Cost %	31%	61%	72%	70%	66%	64%	66%	63%	65%
Employee Cost %	10%	22%	27%	14%	12%	12%	15%	10%	9%
Other Expenses %	17%	30%	45%	18%	7%	10%	7%	13%	12%
Operating Profit	112	-21	-50	-5	38	33	37	84	80
OPM %	42%	-14%	-44%	-2%	15%	13%	13%	14%	14%
	28	109	67	15	14	18	12	12	16
Exceptional items		-0	-127					-11	-11
Interest	2	140	75	2	1	3	5	11	12
Depreciation	4	3	3	3	4	4	4	25	25
Profit before tax	134	-55	-188	5	47	45	41	49	48
	0%			-143%	-41%	25%	25%	23%	20%
Current tax	1				-0	0	0	4
Deferred tax	-0	-14	-6	-7	-19	11	10	7
	134	-41	-182	13	66	34	31	38	39
YOY Profit Growth %		-130.44%			422.99%	-49.26%	-9.20%	22.88%
EPS in Rs	4.57	-0.20	-6.00	0.40	2.09	1.06	0.96	1.18	1.21
Dividend Payout %					48%	95%	104%	102%

Compounded Sales Growth

5 Years:: 39%
3 Years:: 32%
TTM:: 88%

Compounded Profit Growth

3 Years:: -17%
TTM:: 23%

Stock Price CAGR

5 Years:: 2%
3 Years:: 18%
1 Year:: 9%

Return on Equity

4 Years:: 5%
Last Year:: 3%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	64	64	64	64
Reserves	5,059	5,294	5,608	5,762
	297	329	188	3,203
Long term borrowings				3,035
Short term borrowings	293	324	185	152
	413	462	582	1,279
Trade payables	313	363	429	461
Current liabilities	692	769	746	729
Total Liabilities	5,833	6,148	6,442	10,308
	283	256	306	338
Gross block	496	471	550	608
Accumulated depreciation	212	214	245	269
Goodwill & intangibles	4,462	4,461	4,835	8,281
CWIP	13	10	15	23
	5,537	5,882	6,121	9,946
Inventories	458	468	518	764
Trade receivables	208	283	367	384
Cash & equivalents	37	80	67	111
Current assets	908	1,214	1,104	1,367
Total Assets	5,833	6,148	6,442	10,308

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	92	246	380	226
Profit for the year	310	267	347	197
Working capital changes	-240	-44	-27	-211
Direct taxes paid	-1	-3	3	-30
	-85	-178	-224	-2,910
Fixed assets purchased	-45	-29	-66	-102
Fixed assets sold	1	2	1	1
Investments purchased	-41	-164
Investments sold	0	0	207	42
	-139	-26	-186	2,698
Proceeds from borrowings				2,890
Repayment of borrowings	-250	-63		-25
Interest paid	-16	-24	-14	-87
Dividends paid	-32	-32	-32	-38
Net Cash Flow	-132	43	-30	15
Free Cash Flow	47	218	314	125

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2018	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	0.0%	6.9%	3.0%	6.5%	6.2%	5.1%	6.3%	3.4%
Operating margin	24.9%	18.2%	18.4%	17.2%	15.0%	13.2%	14.0%	12.9%
Net margin	26.6%	8.0%	6.4%	15.4%	13.8%	11.5%	12.8%	5.0%
Interest coverage	89.08	1.87	2.34	13.00	19.09	11.84	30.90	3.35
Tax rate	8.8%	-16.9%	-5.8%	-0.9%	-6.7%	-2.6%	3.3%	14.4%
Book value / share	₹24	₹120	₹144	₹152	₹161	₹168	₹178	₹183

Balance-sheet ratios

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROCE	6.0%	5.3%	6.5%	3.4%
Debt / equity	0.06	0.06	0.03	0.55
Current ratio	1.31	1.58	1.48	1.88
Debtor days	34	45	50	36
Inventory days	145	149	147	177
Days payable	99	116	122	107
Cash conversion cycle	80	78	75	106
Working capital days	35	70	49	59

ROE = profit for shareholders ÷ average net worth (paid-up capital + reserves, from each year's March results filed with NSE). Interest coverage = (profit before tax + interest) ÷ interest. ROCE = EBIT ÷ (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; working capital days = (current assets − current liabilities) ÷ sales × 365. Balance-sheet ratios are shown for the years whose full balance sheet is available (Yahoo Finance and NSE filings from FY2025).

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 69.64%
FIIs 3.56%
DIIs 19.39%
Public 7.41%

%	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	69.15%	69.62%	69.62%	69.62%	69.62%	69.63%	69.63%	69.63%	69.63%	69.63%	69.64%	69.64%
	3.25%	3.26%	3.29%	3.37%	3.37%	3.29%	3.25%	3.43%	3.27%	3.18%	3.32%	3.56%
Foreign portfolio investors (Cat. I)	3.10%	3.10%	3.10%	3.14%	3.15%	3.14%	3.05%	3.19%	3.07%	2.98%	3.08%	3.35%
Foreign portfolio investors (Cat. II)	0.15%	0.16%	0.19%	0.22%	0.22%	0.15%	0.20%	0.24%	0.20%	0.19%	0.24%	0.22%
	19.68%	19.42%	19.44%	20.36%	20.12%	19.76%	19.28%	18.76%	18.58%	18.87%	19.14%	19.39%
Mutual funds	8.35%	8.25%	8.38%	11.97%	11.87%	11.61%	18.39%	18.15%	18.11%	18.43%	18.73%	18.72%
Insurance companies	1.04%	1.00%	0.86%	0.86%	0.90%	0.80%	0.80%	0.53%	0.38%	0.39%	0.29%	0.56%
Alternative investment funds	10.28%	10.16%	10.20%	7.53%	7.35%	7.35%	0.08%	0.08%	0.09%	0.05%	0.11%	0.11%
	7.92%	7.71%	7.65%	6.66%	6.89%	7.31%	7.83%	8.18%	8.52%	8.31%	7.91%	7.41%
Retail (up to ₹2 lakh)	5.23%	5.06%	4.94%	4.19%	4.37%	4.72%	5.04%	5.33%	5.60%	5.43%	5.45%	5.20%
HNIs (above ₹2 lakh)	1.29%	1.19%	1.19%	1.19%	1.19%	1.19%	1.19%	1.04%	1.04%	1.04%	0.70%	0.54%
NRIs	0.45%	0.53%	0.57%	0.47%	0.49%	0.55%	0.59%	0.55%	0.59%	0.59%	0.54%	0.53%
Bodies corporate	0.50%	0.49%	0.49%	0.39%	0.41%	0.42%	0.53%	0.77%	0.55%	0.56%	0.50%	0.48%
IEPF	0.14%	0.14%	0.16%	0.16%	0.16%	0.16%	0.16%	0.16%	0.17%	0.17%	0.17%	0.17%
No. of Shareholders	75,369	69,138	63,973	60,981	64,037	64,979	66,514	77,188	80,105	80,671	86,866	86,160

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding Zydus Wellness

Holder (above 1%)	Stake
Parag Parikh Flexi Cap FundMutual fund	7.33%
Nippon India Small Cap FundMutual fund	5.78%
Quant Small Cap FundMutual fund	4.02%
Bajaj Finserv Small Cap FundMutual fund	1.17%

As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 18.72% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 17 Jul 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

No recent coverage found.

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Zydus Wellness Limited

What is the share price of Zydus Wellness Limited today?

Zydus Wellness Limited (ZYDUSWELL) last traded at ₹512.75 on NSE (16 Oct 2026, 3:30 PM IST). Prices may be delayed.

What is the market cap of Zydus Wellness Limited?

About ₹16,314 crore at the latest price.

What is the P/E ratio of Zydus Wellness Limited?

About 86.6 times its earnings over the last 12 months.

Is Zydus Wellness Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Zydus Wellness Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

Zydus Wellness Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About Zydus Wellness Limited

Peer comparison

Quarterly Results

Profit & Loss

Projection — your assumptions

Related party transactions

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Balance-sheet ratios

Shareholding Pattern

Mutual funds & institutions holding Zydus Wellness

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Latest news

In the news

From the company (NSE)

Questions about Zydus Wellness Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next